Intimation under Regulation 30(5) of SEBI (LODR) Regulations, 2015
Awaiting price reaction for this filing.
The Board of Directors approved the audited financial results for Q4 and FY ended March 31, 2026. Revenue from operations grew 24% to ₹33,854.37 Lakhs from ₹27,279.11 Lakhs in the previous year. The company returned to profitability with a net profit of ₹15.70 Lakhs versus a loss of ₹468.56 Lakhs in FY 2024-25. However, the profit was significantly impacted by an exceptional loss of ₹4,705.30 Lakhs on the sale of investment in subsidiary Hindusthan Speciality Chemicals Limited to DCM Shriram Limited. The Board recommended a final dividend of Rs. 0.50 per share (25%) for FY 2025-26 and approved a bonus equity issue in the ratio of 2:1 (2 new shares for every 1 existing share), which will triple the equity share count from 72.14 lakh to 2.16 crore shares. The statutory auditor issued an unmodified (clean) opinion on the financial statements.
The company achieved strong revenue growth of 24% and returned to profitability, but the large exceptional loss on the subsidiary sale means the underlying operating profit was largely consumed by this one-time item. The bonus issue will increase liquidity and affordability of shares for retail investors. The clean audit opinion provides confidence in financial reporting quality.